---
title: "\"Performance\" BIOSTAR PHARM-B's annual loss narrowed to 131 million RMB, no dividend declared"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281107512.md"
description: "BIOSTAR PHARM-B announced its 2025 annual performance, with revenue of RMB 33.36 million, a year-on-year decrease of 53.6%. Losses narrowed to RMB 131 million, compared to a loss of RMB 144 million in the same period last year; loss per share was RMB 0.36. No dividend was declared"
datetime: "2026-03-31T01:42:33.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281107512.md)
  - [en](https://longbridge.com/en/news/281107512.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281107512.md)
---

# "Performance" BIOSTAR PHARM-B's annual loss narrowed to 131 million RMB, no dividend declared

BIOSTAR PHARM-B (02563.HK) announced its 2025 annual results, with revenue of RMB 33.36 million, a year-on-year decrease of 53.6%. Losses narrowed to RMB 131 million, compared to a loss of RMB 144 million in the same period last year; loss per share is RMB 0.36. No dividend is declared

### Related Stocks

- [02563.HK](https://longbridge.com/en/quote/02563.HK.md)
- [513700.CN](https://longbridge.com/en/quote/513700.CN.md)

## Related News & Research

- [The brutal stock sell-off is good news for the SpaceX IPO, market pros say](https://longbridge.com/en/news/289301851.md)
- [SpaceX's IPO May Be The Ultimate Scarcity Trade As $150 Billion Chases Limited Shares](https://longbridge.com/en/news/289197384.md)
- [Farmland: Iowa value study tracks historic price reversals](https://longbridge.com/en/news/289169687.md)
- [Abrdn Income Credit Strategies Fund 5.250% PER PFD A declares $0.3281 dividend](https://longbridge.com/en/news/289099728.md)
- [Gwynne Shotwell, the 'glue' executing Musk's lofty SpaceX ambitions](https://longbridge.com/en/news/289035830.md)